Showing 1 - 20 results of 30 for search 'Jianchun DUAN', query time: 0.04s
Refine Results
-
1
-
2
Mechanism of Platinum Derivatives Induced Kidney Injury by Feifei YAN, Jianchun DUAN, Jie WANG
Published 2015-09-01
Article -
3
-
4
Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC by Yiyi Huang, Yi-Fung Chau, Hua Bai, Xinyu Wu, Jianchun Duan
Published 2023-09-01
Article -
5
-
6
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung c... by Yue Chai, Xinyu Wu, Yifeng Zou, Xue Zhang, Hua Bai, Mei Dong, Jianchun Duan
Published 2022-11-01
Article -
7
-
8
-
9
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study by Kailun Fei, Kailun Fei, Gang Guo, Gang Guo, Jie Wang, Jie Wang, Zhijie Wang, Zhijie Wang, Yan Wang, Yan Wang, Xuezhi Hao, Xuezhi Hao, Jia Zhong, Jia Zhong, Qinxiang Guo, Wei Guo, Wenzhong Su, Likun Zan, Jiaxi Xu, Fengwei Tan, Xiaofei Zhuang, Xiaofei Zhuang, Jianchun Duan, Jianchun Duan, Jianchun Duan
Published 2023-03-01
Article -
10
Therapeutic guidance of tumor mutation burden on immune checkpoint inhibitors in advanced non-small cell lung cancer: a systematic review and comprehensive meta-analysis by Jie Zhao, Yiting Dong, Hua Bai, Jianchun Duan, Guoqiang Wang, Jiachen Xu, Jie Wang, Zhijie Wang
Published 2022-03-01
Article -
11
-
12
-
13
Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy by Jie Zhao, Yiting Dong, Hua Bai, Fan Bai, Xiaoyan Yan, Jianchun Duan, Rui Wan, Jiachen Xu, Kailun Fei, Jie Wang, Zhijie Wang
Published 2023-10-01
Article -
14
-
15
Alterations in EGFR and related genes following neo-adjuvant chemotherapy in Chinese patients with non-small cell lung cancer. by Shuhang Wang, Tongtong An, Jianchun Duan, Lijian Zhang, Meina Wu, Qinghua Zhou, Jinfeng Chen, Minglei Zhuo, Lu Yang, Yuyan Wang, Hua Bai, Jie Wang
Published 2013-01-01
Article -
16
Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppress... by Chao Wang, Kailun Fei, Lihui Liu, Jianchun Duan, Zhijie Wang, Sini Li, Jiachen Xu, Xue Zhang, Yanhua Tian, Yan Qu, Hua Bai, Jie Wang
Published 2023-07-01
Article -
17
Dynamic toxicity landscape of immunotherapy for solid tumors across treatment lines by Lihui Liu, Sini Li, Guoqiang Wang, Yan Qu, Zhijie Wang, Jianchun Duan, Chao Wang, Pei Xue, Xue Zhang, Zixiao Ma, Hua Bai, Jie Wang
Published 2023-09-01
Article -
18
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non–small cell lung cancer by Geyun Chang, Weihua Li, Hua Bai, Jianchun Duan, Zhijie Wang, Xinyang Du, Ruofei Yu, Yaxi Wang, Minghao Wang, Yixiang Zhu, Xue Zhang, Li Li, Rui Wan, Jie Wang
Published 2022-11-01
Article -
19
A single-cell characterised signature integrating heterogeneity and microenvironment of lung adenocarcinoma for prognostic stratificationResearch in context by Jiachen Xu, Yundi Zhang, Man Li, Zhuo Shao, Yiting Dong, Qingqing Li, Hua Bai, Jianchun Duan, Jia Zhong, Rui Wan, Jing Bai, Xin Yi, Fuchou Tang, Jie Wang, Zhijie Wang
Published 2024-04-01
Article -
20
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy by Jiefei Han, Yiting Dong, Xiuli Zhu, Alexandre Reuben, Jianjun Zhang, Jiachen Xu, Hua Bai, Jianchun Duan, Rui Wan, Jie Zhao, Jing Bai, Xuefeng Xia, Xin Yi, Chao Cheng, Jie Wang, Zhijie Wang
Published 2024-02-01
Article